Literature DB >> 803203

Dimethyltryptamine levels in blood of schizophrenic patients and control subjects.

B Angrist, S Gershon, G Sathananthan, R W Walker, B Lopez-Ramos, L R Mandel, W J Vandenheuvel.   

Abstract

A gas chromatographic-mass spectrometric determination of blood N,N-dimethyltryptamine in normal controls and schizophrenic patients was carried out with a sensitivity limit of 0.05 ng/ml whole blood. Although the results appear to suggest that the mean DMT level was higher in the total patient group, those patients with acute psychosis, female patients and patients with suspiciousness scores on the BPRS of 4 or over, the differences were not statistically significant.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 803203     DOI： 10.1007/BF00428697

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  7 in total

1.  Review of rapid urine tests for phenothiazine and related drugs.

Authors:  F M FORREST; A S MASON
Journal:  Am J Psychiatry       Date:  1961-10       Impact factor: 18.112

Review 2.  N,N-dimethyltryptamine--a possible relationship to schizophrenia?

Authors:  R J Wyatt; J C Gillin; J Kaplan; R Stillman; L Mandel; H S Ahn; W J VandenHeuvel; R W Walker
Journal:  Adv Biochem Psychopharmacol       Date:  1974

3.  Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma.

Authors:  R W Walker; H S Ahn; G Albers-Schönberg; L R Mandel; W J Vandenheuvel
Journal:  Biochem Med       Date:  1973-08

4.  Blood dimethyltryptamine concentrations in psychotic disorders.

Authors:  J F Lipinski; L R Mandel; H S Ahn; W J Vanden Heuvel; R W Walker
Journal:  Biol Psychiatry       Date:  1974-08       Impact factor: 13.382

5.  Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients.

Authors:  R J Wyatt; L R Mandel; H S Ahn; R W Walker; W J Vanden Heuvel
Journal:  Psychopharmacologia       Date:  1973-07-19

6.  Action of psychotogenic drugs on single midbrain raphe neurons.

Authors:  G K Aghajanian; W E Foote; M H Sheard
Journal:  J Pharmacol Exp Ther       Date:  1970-02       Impact factor: 4.030

7.  Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.

Authors:  R J Wyatt; D L Murphy; R Belmaker; S Cohen; C H Donnelly; W Pollin
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728
  7 in total
  7 in total

1.  The excretion of dimethyltryptamine in psychiatric patients.

Authors:  R M Murray; M C Oon
Journal:  Proc R Soc Med       Date:  1976-11

Review 2.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

3.  Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects.

Authors:  M C Oon; R M Murray; R Rodnight; M P Murphy; J L Birley
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

4.  Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.

Authors:  D Ruffing; B Kovacic; S Demetriou; E F Domino
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

Review 5.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

6.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Authors:  Nicholas V Cozzi; Anupama Gopalakrishnan; Lyndsey L Anderson; Joel T Feih; Alexander T Shulgin; Paul F Daley; Arnold E Ruoho
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

7.  Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.

Authors:  Uyen B Chu; Sevahn K Vorperian; Kenneth Satyshur; Kelsey Eickstaedt; Nicholas V Cozzi; Timur Mavlyutov; Abdol R Hajipour; Arnold E Ruoho
Journal:  Biochemistry       Date:  2014-04-28       Impact factor: 3.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.